NCT05672212

Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease

Effect of Goal-directed Analgesia Using ANI (Analgesia/Nociception Index) During General Anesthesia in Children Undergoing EDAS (Encephaloduroarteriosynangiosis) Surgery for Moyamoya Disease: a Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.

Conditions

• Pain

Interventions

Type	Name	Description
DEVICE	ANI (Analgesia/Nociception Index) monitoring	Intraoperative analgesia was provided by injection of sufentanil, which was performed according to ANI monitor.
DEVICE	standard monitoring	Intraoperative analgesia was provided by injection of sufentanil, which was performed according to the clinician's assessment.
DRUG	Sufentanil	Sufentanil

Timeline

• Start date: 2023-01-04
• Primary completion: 2025-01-04
• Completion: 2025-01-04
• First posted: 2023-01-05
• Last updated: 2023-01-09

Locations

1 site across 1 country: South Korea